Increased expression of Smad proteins, and in particular Smad3, in oral lichen planus compared to normal oral mucosa

Journal of Oral Pathology and Medicine

Volumn 39, Issue 8, 2010, Pages 639-644

  Danielsson, K ^a   Wahlin, Y B ^a   Coates, P J ^b   Nylander, K ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

epithelial mesenchymal transition; oral lichen planus; smad; transforming growth factor

Indexed keywords

SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MALE; MOUTH MUCOSA; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; PRECANCEROUS CONDITIONS; SMAD PROTEINS; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 77956295246     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00902.x     Document Type: Article

References (47)

1. Axell T, Rundqvist L. Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 1987 15 : 52 6.
2. Ebrahimi M, Wahlin YB, Coates PJ, et al. Detection of antibodies against p63 and p73 isoforms in sera from patients diagnosed with oral lichen planus. J Oral Pathol Med 2007 36 : 93 8.
3. Van Der Meij EH, Van Der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003 32 : 507 512.
4. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002 13 : 350 365.
5. Bloor BK, Malik FK, Odell EW, et al. Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 187 195.
6. Neppelberg E, Johannessen AC, Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci 2001 109 : 361 364.
7. Rödström PO, Jontell M, Mattsson U, et al. Cancer and oral lichen planus in a swedish population. Oral Oncol 2004 40 : 131 138.
8. Van Der Meij EH, Mast H, Van Der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 2007 43 : 742 748.
9. Bermejo-Fenoll A, Sanchez-Siles M, Lopez-Jornet P, et al. Premalignant nature of oral lichen planus. A retrospective study of 550 oral lichen planus patients from south-eastern Spain. Oral Oncol 2009 45 : e54 6.
10. Ingafou M, Leao JC, Porter SR, et al. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis 2006 12 : 463 468.
11. Hsue SS, Wang WC, Chen CH, et al. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007 36 : 25 9.
12. Carbone M, Arduino PG, Carrozzo M, et al. Course of oral lichen planus: a retrospective study of 808 northern Italian patients. Oral Dis 2009 15 : 235 243.
13. Pakfetrat A, Javadzadeh-Bolouri A, Basir-Shabestari S, et al. Oral lichen planus: a retrospective study of 420 Iranian patients. Med Oral Patol Oral Cir Bucal 2009 14 : E315 8.
14. Lo Muzio L, Mignogna MD, Favia G, et al. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 1998 34 : 239 246.
15. Curadoa MP, Hashibeb M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 2009 21 : 194 200.
16. Parkin MD, Bray F, Ferlay J, et al. Global cancer statstics. CA Cancer J Clinic 2005 55 : 74 108.
17. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol 2000 45 : 301 308.
18. Cuffari L, Tesseroli De Siqueira JT, Nemr K, et al. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 102 : 56 61.
19. Kalluri R, Neilson EG. Epihelial-mesenchymal transition and its implications for fibrosis. J Clinl Invest 2003 12 : 1776 1784.
20. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003 15 : 740 746.
21. Thompson EW, Newgreen DF. Carcinoma invasion and metastasis:a role for epithelial-mesenchymal transition? Cancer Res 2005 65 : 5991 5995.
22. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009 119 : 1420 1428.
23. Moustakas A, Heldin CH. Signaling networks guiding eiphelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007 98 : 1512 1520.
24. Massagué J. TGF-β siganl transduction. Annu RevBiochem 1998 67 : 753 791.
25. Ten Dijke P, Hill CS. New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004 29 : 265 273.
26. Siegel PM, Massagué J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 2003 3 : 807 820.
27. Glick AB, Perez-Lorenzo R, Mohammed J. Context dependent regulation of cutaneous immunological responses by TGFβ1 and its role in skin carcinogenesis. Carcinogenesis 2008 29 : 9 14.
28. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992 359 : 693 699.
29. Pardali K, Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 2007 1775 : 21 62.
30. Wakefield LM, Roberts AB. TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002 12 : 22 9.
31. Derynck R, Akhurst RJ, Balmain A. TGF-β signalling in tumor suppression and cancer progression. Nat Genet 2001 29 : 117 129.
32. Lu SL, Reh D, Li AG, et al. Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis and epithelial hyperproliferation. Cancer Res 2004 64 : 4405 4410.
33. Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005 19 : 2783 2810.
34. Nakao A, Afrakhte M, Morén A, et al. Identification of Smad7 a TGFβ-inducible antagonist of TGF-β signalling. Nature 1997 389 : 631 635.
35. Karatsaidis A, Schreurs O, Axéll T, et al. Inhibition or the transforming growth factor-β/Smad signaling pathway in the epithelium of oral lichen. J Invest Dermatol 2003 121 : 1 8.
36. Karatsaidis A, Schreurs O, Helgeland K, et al. Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J Oral Pathol Med 2003 32 : 275 281.
37. Van Der Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 2009 14 : E310 4.
38. Vincent T, Neve EP, Johnson JR, et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 2009 11 : 943 950.
39. Prime SS, Pring M, Davies M, et al. TGF-β Signal Transduction in oro-facial health and non-malignant disease. Crit Rev Oral Biol Med 2004 15 : 324 336.
40. Kim SG, Kim HA, Jong HS, et al. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 2005 16 : 4672 4683.
41. Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006 26 : 654 667.
42. Millet C, Zhang YE. Roles of Smad3 in TGF-β signaling during carcinogenesis. Crit Rev Eukaryot Gene Expr 2007 17 : 281 293.
43. Li AG, Lu SL, Zhang MX, et al. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res 2004 64 : 7836 7845.
44. Landström M, Heldin NE, Bu S, et al. Smad7 mediates apoptosis induced by transforming growth factor b in prostatic carcinoma cells. Curr Biol 2000 10 : 535 538.
45. Lallemand F, Mazars A, Prunier C, et al. Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells. Oncogene 2001 20 : 879 884.
46. Schmierer B, Hill CS. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol Cell Biol 2005 25 : 9845 9858.
47. Wrighton KH, Lin X, Feng XH. Phospho-control of TGF-beta superfamily signaling. Cell Res 2009 19 : 8 20. None declared